妊娠期缺铁性贫血产妇规范性服用铁剂对预防产后出血及改善缺铁性贫血的价值

The Value of Normative Iron Administration for Pregnant Women with Iron-deficiency Anemia in Preventing Postpartum Hemorrhage and Improving Iron-deficiency Anemia

目的研究妊娠期缺铁性贫血产妇在采取规范性服用铁剂治疗时的价值。方法方便选取该院2019年3月—2020年6月收治的71例妊娠期缺铁性贫血产妇,以随机方式分为Ⅰ组(n=36例)和Ⅱ组(n=35例)。Ⅱ组不采取铁剂治疗,单纯使用食补,Ⅰ组采取铁剂治疗;比较并发症发生率、产后2 h出血量,及治疗前后的血清指标。结果Ⅰ组产后2 h出血量为(162.24±42.61)mL,低于Ⅱ组的(395.65±76.43)mL,比较差异有统计学意义(t=15.952,P<0.05)。Ⅰ组并发症发生率为5.55%,低于Ⅱ组的25.71%,差异有统计学意义(χ^(2)=5.508,P=0.018)。治疗前,Ⅰ组血清铁蛋白(SF)值为(13.24±3.21)μg/L,Ⅱ组治疗前SF值为(13.54±3.06)μg/L,差异无统计学意义(t=0.402,P>0.05)。Ⅰ组分娩前SF值为(22.65±7.01)μg/L,Ⅱ组分娩前SF值为(17.32±6.24)μg/L,差异有统计学意义(t=3.380,P<0.001)。治疗前,Ⅰ组血红蛋白(Hb)值为(100.36±5.41)g/L,Ⅱ组治疗前Hb值为(101.32±5.62)g/L,对比差异无统计学意义(t=0.733,P>0.05)。Ⅰ组分娩前Hb值为(116.32±9.65)g/L,Ⅱ组分娩前Hb值为(107.32±8.62)g/L,差异有统计学意义(t=4.140,P>0.05)。结论规范性服用铁剂对于妊娠期缺铁性贫血产妇而言,可显著降低并发症发生率和出血量,优化血清指标,应用价值较高。

Objective To study the value of iron-deficiency anemia women in pregnancy in taking standardized iron treatment.Methods Convenient select 71 cases of iron-deficiency anemia during pregnancy were included in the hospital from March 2019 to June 2020,and they were randomly divided into group I(n=36 cases)and group II(n=35 cases),Group II did not Take iron treatment,simply use food tonic,groupⅠtake iron treatment;compared the incidence of complications,the amount of bleeding at 2 h postpartum,and the serum indexes before and after treatment.Results The blood loss at 2 h postpartum in group I was(162.24±42.61)mL,which was lower than that in group II(395.65±76.43)mL,and the difference was statistically significant(t=15.952,P<0.05).The complication rate in group I was 5.55%,which was lower than 25.71%in group II,the difference was statistically significant(χ^(2)=5.508,P=0.018).Before treatment,the serum ferritin(SF)value of group I was(13.24±3.21)μg/L,and the SF value of group II before treatment was(13.54±3.06)μg/L,the difference was not statistically significant(t=0.402,P>0.05).The SF value of componentⅠbefore delivery was(22.65±7.01)μg/L,and the SF value of componentⅡbefore delivery was(17.32±6.24)μg/L,the difference was statistically significant(t=3.380,P<0.001).Before treatment,the hemoglobin(Hb)value of group I was(100.36±5.41)g/L,and the Hb value of group II before treatment was(101.32±5.62)g/L,the difference was not statistically significant(t=0.733,P>0.05).The Hb value of componentⅠbefore delivery was(116.32±9.65)g/L,the Hb value of componentⅡbefore delivery was(107.32±8.62)g/L,the difference was statistically significant(t=4.140,P<0.05).Conclusion Standardized iron administration could significantly reduce the incidence of complications and blood loss for women with iron-deficiency anemia during pregnancy,optimize serum indexes,and have high application value.